In the pharmaceutical arena, a number of new developments in terms of legislation and executive orders have signaled that sweeping changes may be coming, particularly when it comes to drug pricing.
More specifically, the Trump administration and Republicans in Congress want to roll back some of the 2022 Inflation Reduction
Let’s